Class of Stock [Axis] Class A Common Stock, $0.0001 par value per share Warrants to purchase Class A Common Stock, $0.0001 par value per share Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stocks [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Product and Service [Axis] Long COVID Program [Member] Antidilutive Securities [Axis] Equity Option [Member] Warrant [Member] Restricted Stock Units (RSUs) [Member] Cash and Cash Equivalents [Axis] Cash [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Investment Type [Axis] US Treasury Bill Securities [Member] Related and Nonrelated Parties [Axis] Acuitas Group Holdings, LLC [Member] Award Type [Axis] Warrants [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Derivative Instrument [Axis] Stock Options [Member] Title and Position [Axis] Director [Member] Employees [Member] Consultant [Member] Award Date [Axis] Year 2027 [Member] Year 2028 [Member] Year 2029 [Member] Year 2030 [Member] Year 2031 [Member] Operating Activities [Axis] Office Leases [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS: Cash and cash equivalents Grant receivable Prepaid and other current assets Total current assets Operating lease right-of-use asset, net Intangible assets, net Goodwill TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable and accrued expenses Current portion of operating lease liability Total current liabilities Operating lease liability, net of current portion TOTAL LIABILITIES Commitments and contingencies (Note 8) STOCKHOLDERS' EQUITY: Preferred stock; $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding Common stock, $0.0001 par value; 800,000,000 shares authorized at March 31, 2026 and June 30, 2025; 7,544,675 shares issued of which 7,541,839 shares outstanding at March 31, 2026; and 1,917,061 shares issued of which 1,914,224 shares are outstanding at June 30, 2025 Additional paid in capital Accumulated deficit Treasury stock Total stockholders' equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] OPERATING EXPENSES: Amortization of intangible assets Research and development expenses General and administrative expenses TOTAL OPERATING EXPENSES LOSS FROM OPERATIONS OTHER (INCOME) EXPENSE: Change in fair value of derivative liabilities Interest expense Interest income TOTAL OTHER INCOME, NET NET LOSS Deemed dividend related to ratchet adjustment to warrants NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS NET LOSS PER COMMON SHARE - Basic - Diluted WEIGHTED AVERAGE NUMBER OF COMMON  SHARES OUTSTANDING - Basic - Diluted Beginning balance, value Beginning balance, shares Stock - based compensation - stock options Stock-based compensation - restricted stock units and restricted shares Stock-based compensation - restricted stock units Issuance of common stock from vesting of restricted stock units Issuance of common stock from vesting of restricted stock units, shares Exercise of warrants Exercise of warrants, shares Cashless exercise of warrants Cashless exercise of warrants, shares Stock-based compensation - issuance of common stock for services rendered Stock-based compensation - issuance of common stock for services rendered, shares Proceeds from issuance of common stock, net of costs of  $1,543,038 Proceeds from issuance of common stock, net of costs of $747,408, shares Issuance of additional shares for fractional shares effected by the reverse split Issuance of additional shares for fractional shares effected by the reverse split, shares Deemed dividend for ratchet adjustment to warrants Net Loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation - restricted stock units and restricted shares Stock based compensation expense - stock options Stock based compensation expense - issuance of common stock for services rendered Amortization of financing costs Accretion of unearned loan discount Accretion of loan premium Non-cash lease expense from right-of-use assets Change in fair value of derivative liabilities Changes in operating assets and liabilities: Grant receivable Prepaid and other current assets Accounts payable and accrued expenses Operating lease liabilities Net cash used in operating activities CASH FLOWS FROM FINANCING ACTIVITIES: Net proceeds from issuance of common stock Proceeds from exercise of warrants Payment of loan premium Payment of loan premium Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for interest SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES: Deemed dividend for ratchet adjustment to warrants Organization, Consolidation and Presentation of Financial Statements [Abstract] Background Information Liquidity and Going Concern Accounting Policies [Abstract] Significant Accounting Policies Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Fair Value Disclosures [Abstract] Fair Value Measurements Equity [Abstract] Equity Transactions Leases Leases Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Employee Benefit Plan Employee Benefit Plan Segment Reporting [Abstract] Segment Reporting Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Terminated [Flag] Basis of Presentation – Interim Financial Information Reverse stock split Cash and cash equivalents Concentration of Credit Risk in the Financial Service Industry Fair value measurement of assets and liabilities Net Loss per Common Share Grant program Segment Reporting Schedule of dilutive securities were excluded from the computation of diluted loss per share Schedule of intangible assets Measured at fair value on a recurring basis Schedule of summarizes the activity relating to the Company’s stock options Schedule of assumptions used Schedule of vesting of restricted common stock Summary of warrants activity Schedule of expiration of the warrants outstanding Schedule of deferred tax assets Schedule of future estimated minimum lease payments under non-cancelable operating leases Schedule of weighted average remaining lease term and discount rate Schedule of segment reporting information Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Costs and expenses Research and development expense Working capital Cash and cash equivalent Stockholders' equity Accumulated deficit Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Reverse split Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Intellectual Property Less: Accumulated Amortization Intellectual Property, net Amortization expenses Useful life Remaining amortization expense Fair Value, off-Balance-Sheet Risk [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Total Offsetting Assets [Table] Offsetting Assets [Line Items] Options outstanding at beginning Weighted average exercise price, options outstanding at beginning Weighted remaining average contractual term, beginning Aggregate intrinsic value, outstanding at beginning Options granted Weighted average exercise price, options granted Weighted remaining average contractual term, options granted Aggregate intrinsic value. options granted Options expired Weighted average exercise price, Options expired Options outstanding at ending Weighted average exercise price, options outstanding at ending Weighted remaining average contractual term, ending Aggregate intrinsic value, outstanding at ending Options exercisable Weighted average exercise price, options exercisable Weighted average remaining contractual term, options exercisable Aggregate intrinsic value. options exercisable Expected life of options (in years) Expected volatility Risk free interest rate Dividend Yield Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of shares, beginning Weighted average exercise price, beginning Number of shares, granted Weighted average exercise price, granted Number of shares, vested Weighted average grant date fair value per share, vested Number of shares unvested at ending Weighted average grant date fair value per share unvested at ending Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of shares, beginning Weighted average remaining life (Years) Weighted average remaining life (Years), granted Number of shares, canceled Weighted average grant date fair value per share, canceled Number of shares, expired Weighted average exercise price, expired Number of shares, ending Weighted average exercise price, ending Total outstanding warrants Deemed dividend Stock price Exercise price Remaining term Risk free rate Volatility Number of shares issued Number of pre-funded units Additional warrants purchased Proceeds from offering Share price description Number of stock option granted Number of awarded bonus and retention incentive stock options Stock option vested Stock issued during period for service Rsu granted, grant date fair value Prefunded warrants Total operating lease liability Year ending June 30, 2026 (Remaining 3 months) 2027 2028 2029 Total minimum lease payments Less amount representing interest Present value of future minimum lease payments Weighted average remaining lease term (Years) Operating leases Weighted average discount rate Operating leases Annual rent Monthly rent Operating lease cost Cash paid for amounts included in measurement of operating lease liabilities Employee's contributions Clinical studies Clinical teams Chemistry, manufacturing and controls Other research and development expenses General and administrative expenses Amortization of intangible assets Other income, net Net loss Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Gain (Loss) on Sale of Derivatives Interest Income, Other Nonoperating Income (Expense) Income (Loss) Attributable to Parent, before Tax Shares, Outstanding StockbasedCompensationRestrictedStockUnitsAndRestrictedShares AccretionOfUnearnedLoanDiscount Derivative, Gain (Loss) on Derivative, Net IncreaseDecreaseInGrantReceivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Cash Provided by (Used in) Operating Activity, Including Discontinued Operation PaymentsForLoan PaymentOfLoanPremium Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation DeemedDividendOfRatchetAdjustmentsToWarrants Lessee, Operating Leases [Text Block] EmployeeBenefitPlanTextBlock Cash and Cash Equivalents, Policy [Policy Text Block] Segment Reporting, Policy [Policy Text Block] AccumulatedDeficit Finite-Lived Intangible Assets, Accumulated Amortization Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount ClinicalStudies SellingGeneralAndAdministrativeExpenses Amortization Other Income NetLoss